{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:00:44Z","timestamp":1790355644011,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Public Health Service","award":["P51RR00169"],"award-info":[{"award-number":["P51RR00169"]}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["U01 AI74512"],"award-info":[{"award-number":["U01 AI74512"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,14]]},"DOI":"10.1093\/infdis\/jiy238","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T19:09:05Z","timestamp":1524251345000},"page":"856-867","source":"Crossref","is-referenced-by-count":13,"title":["A Lipid\/DNA Adjuvant\u2013Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge"],"prefix":"10.1093","volume":"218","author":[{"given":"Timothy D","family":"Carroll","sequence":"first","affiliation":[{"name":"Center for Comparative Medicine, University of California, Davis"},{"name":"California National Primate Research Center, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinthujan","family":"Jegaskanda","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon R","family":"Matzinger","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, University of California, Davis"},{"name":"California National Primate Research Center, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Fritts","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, University of California, Davis"},{"name":"California National Primate Research Center, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"McChesney","sequence":"additional","affiliation":[{"name":"California National Primate Research Center, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Kent","sequence":"additional","affiliation":[{"name":"Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University"},{"name":"Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity"},{"name":"Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Fairman","sequence":"additional","affiliation":[{"name":"Colby Pharmaceutical Company, Menlo Park"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Miller","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, University of California, Davis"},{"name":"California National Primate Research Center, University of California, Davis"},{"name":"Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California, Davis"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"key\n\t\t\t\t20180814005622_CIT0001","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180814005622_CIT0002","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/nm1210-1389","article-title":"Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine","volume":"16","author":"Nabel","year":"2010","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180814005622_CIT0003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","article-title":"Influenza vaccine immunology","volume":"239","author":"Dormitzer","year":"2011","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180814005622_CIT0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12703\/P6-47","article-title":"Advances in influenza vaccination","volume":"6","author":"Reperant","year":"2014","journal-title":"F1000Prime Rep"},{"key":"key\n\t\t\t\t20180814005622_CIT0005","first-page":"17","article-title":"Using the strains and getting the vaccine licensed\u2013a vaccine manufacturer\u2019s view","volume":"115","author":"Gerdil","year":"2003","journal-title":"Dev Biol (Basel)"},{"key":"key\n\t\t\t\t20180814005622_CIT0006","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"key":"key\n\t\t\t\t20180814005622_CIT0007","first-page":"1","volume-title":"The compelling need for game-changing influenza vaccines: an analysis of the influenza vaccine enterprise and recommendations for the future","author":"Osterholm","year":"2012"},{"key":"key\n\t\t\t\t20180814005622_CIT0008","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180814005622_CIT0009","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/S0140-6736(17)31274-6","article-title":"Novel influenza A viruses and pandemic threats","volume":"389","author":"Uyeki","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180814005622_CIT0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14712598.2018.1391786","article-title":"Influenza vaccine response: future perspectives","volume":"18","author":"Mameli","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"key\n\t\t\t\t20180814005622_CIT0011","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1016\/S0264-410X(03)00234-2","article-title":"Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice","volume":"21","author":"Takada","year":"2003","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0012","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.coviro.2016.12.002","article-title":"Antibody-dependent cellular cytotoxicity and influenza virus","volume":"22","author":"Vanderven","year":"2017","journal-title":"Curr Opin Virol"},{"key":"key\n\t\t\t\t20180814005622_CIT0013","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","article-title":"Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection","volume":"35","author":"de Vries","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0014","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1128\/JVI.02226-09","article-title":"Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus","volume":"84","author":"Ge","year":"2010","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005622_CIT0015","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1128\/JVI.01631-14","article-title":"Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein","volume":"88","author":"Chen","year":"2014","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005622_CIT0016","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.0811271106","article-title":"HLA class I molecules consistently present internal influenza epitopes","volume":"106","author":"Wahl","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180814005622_CIT0017","doi-asserted-by":"crossref","first-page":"9178","DOI":"10.1073\/pnas.1105624108","article-title":"Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals","volume":"108","author":"Wu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180814005622_CIT0018","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1016\/j.vaccine.2006.01.015","article-title":"An MF59-adjuvanted inactivated influenza vaccine containing A\/Panama\/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A\/Fujian\/2002 than a subunit and a split influenza vaccine","volume":"24","author":"Del Giudice","year":"2006","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0019","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1016\/j.vaccine.2011.05.041","article-title":"Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults","volume":"29","author":"Turley","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0020","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"key\n\t\t\t\t20180814005622_CIT0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2005.12.002","article-title":"Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome-DNA complexes","volume":"69","author":"Gowen","year":"2006","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20180814005622_CIT0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/infdis\/jit540","article-title":"Efficacy of influenza vaccination of elderly rhesus macaques is dramatically improved by addition of a cationic lipid\/DNA adjuvant","volume":"209","author":"Carroll","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180814005622_CIT0023","doi-asserted-by":"crossref","first-page":"12691","DOI":"10.1128\/JVI.00769-10","article-title":"Cationic lipid\/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunity","volume":"84","author":"Hong","year":"2010","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005622_CIT0024","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1016\/j.vaccine.2009.04.054","article-title":"Cationic lipid\/DNA complexes (JVRS-100) combined with influenza vaccine (Fluzone) increases antibody response, cellular immunity, and antigenically drifted protection","volume":"27","author":"Lay","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0025","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.176.12.7335","article-title":"Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes","volume":"176","author":"Zaks","year":"2006","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0026","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.4049\/jimmunol.180.4.2385","article-title":"Interferon-induced expression of MxA in the respiratory tract of rhesus macaques is suppressed by influenza virus replication","volume":"180","author":"Carroll","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0027","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2010.11.024","article-title":"Alphavirus replicon-based adjuvants enhance the immunogenicity and effectiveness of Fluzone in rhesus macaques","volume":"29","author":"Carroll","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0028","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa0906612","article-title":"Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China","volume":"361","author":"Cao","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180814005622_CIT0029","doi-asserted-by":"crossref","first-page":"c4779","DOI":"10.1136\/bmj.c4779","article-title":"Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China","volume":"341","author":"Yu","year":"2010","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180814005622_CIT0030","first-page":"28","volume-title":"WHO manual on animal influenza diagnosis and surveillance","author":"Webster","year":"2002","edition":"1st ed"},{"key":"key\n\t\t\t\t20180814005622_CIT0031","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"Wei","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20180814005622_CIT0032","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1135165","article-title":"Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding specificity","volume":"317","author":"Yang","year":"2007","journal-title":"Science"},{"key":"key\n\t\t\t\t20180814005622_CIT0033","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180814005622_CIT0034","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.4049\/jimmunol.179.7.4732","article-title":"Live attenuated lentivirus infection elicits polyfunctional simian immunodeficiency virus Gag-specific CD8+ T cells with reduced apoptotic susceptibility in rhesus macaques that control virus replication after challenge with pathogenic SIVmac239","volume":"179","author":"Genesc\u00e0","year":"2007","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0035","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1172\/JCI41902","article-title":"Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine","volume":"120","author":"Corti","year":"2010","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180814005622_CIT0036","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan2676","article-title":"Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans","volume":"2","author":"Andrews","year":"2017","journal-title":"Sci Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0037","article-title":"Is it possible to develop a \u201cuniversal\u201d influenza virus vaccine? Potential for a universal influenza vaccine","author":"Crowe","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key\n\t\t\t\t20180814005622_CIT0038","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza A virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0039","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1016\/j.vaccine.2009.08.053","article-title":"Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses","volume":"27","author":"Price","year":"2009","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180814005622_CIT0040","doi-asserted-by":"crossref","first-page":"e9812","DOI":"10.1371\/journal.pone.0009812","article-title":"Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret","volume":"5","author":"Rao","year":"2010","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180814005622_CIT0041","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0042","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"LaMere","year":"2011","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180814005622_CIT0043","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180814005622_CIT0044","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/266052a0","article-title":"Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells","volume":"266","author":"Virelizier","year":"1977","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180814005622_CIT0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1290018","article-title":"Fc or not Fc; that is the question: antibody Fc-receptor interactions are key to universal influenza vaccine design","volume":"13","author":"Jegaskanda","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180814005622_CIT0046","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and protective ability of influenza virus-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection, and experimental challenge","volume":"214","author":"Jegaskanda","year":"2016","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/6\/856\/25469517\/jiy238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T06:47:16Z","timestamp":1693637236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/6\/856\/4986227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,4,26]]},"published-print":{"date-parts":[[2018,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy238","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9,15]]},"published":{"date-parts":[[2018,4,26]]}}}